Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.04
(-1.14%)
USD 25.04
(-1.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 311.75 Million USD | 98.54% |
| 2022 | 157.02 Million USD | 59.69% |
| 2021 | 98.32 Million USD | 71.08% |
| 2020 | 57.47 Million USD | -2.73% |
| 2019 | 59.08 Million USD | 19.48% |
| 2018 | 49.45 Million USD | 106.76% |
| 2017 | 23.91 Million USD | -12.22% |
| 2016 | 27.24 Million USD | 92.82% |
| 2015 | 14.13 Million USD | 37.97% |
| 2014 | 10.24 Million USD | -35.02% |
| 2013 | 15.76 Million USD | 47.22% |
| 2012 | 10.7 Million USD | 6551.46% |
| 2011 | 160.95 Thousand USD | -54.31% |
| 2010 | 352.29 Thousand USD | -78.93% |
| 2009 | 1.67 Million USD | -68.66% |
| 2008 | 5.33 Million USD | 25.82% |
| 2007 | 4.24 Million USD | 10516.67% |
| 2006 | 39.94 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 295.06 Million USD | -5.35% |
| 2024 Q2 | 306.17 Million USD | 3.92% |
| 2023 Q2 | 223.98 Million USD | 2.98% |
| 2023 Q4 | 311.75 Million USD | 8.98% |
| 2023 Q3 | 286.06 Million USD | 27.71% |
| 2023 FY | 311.75 Million USD | 98.54% |
| 2023 Q1 | 217.49 Million USD | 38.51% |
| 2022 Q4 | 157.02 Million USD | 58.62% |
| 2022 Q3 | 98.99 Million USD | 0.95% |
| 2022 Q2 | 98.06 Million USD | 0.48% |
| 2022 FY | 157.02 Million USD | 59.69% |
| 2022 Q1 | 97.59 Million USD | -0.75% |
| 2021 FY | 98.32 Million USD | 71.08% |
| 2021 Q4 | 98.32 Million USD | -4.35% |
| 2021 Q1 | 56.25 Million USD | -2.13% |
| 2021 Q3 | 102.8 Million USD | -3.89% |
| 2021 Q2 | 106.96 Million USD | 90.16% |
| 2020 Q4 | 57.47 Million USD | -3.36% |
| 2020 Q2 | 49.45 Million USD | 5.46% |
| 2020 Q3 | 59.47 Million USD | 20.25% |
| 2020 Q1 | 46.89 Million USD | -20.63% |
| 2020 FY | 57.47 Million USD | -2.73% |
| 2019 Q4 | 59.08 Million USD | 8.02% |
| 2019 Q2 | 65.15 Million USD | -2.03% |
| 2019 Q1 | 66.51 Million USD | 34.5% |
| 2019 FY | 59.08 Million USD | 19.48% |
| 2019 Q3 | 54.69 Million USD | -16.05% |
| 2018 Q1 | 21.19 Million USD | -11.36% |
| 2018 Q4 | 49.45 Million USD | 74.81% |
| 2018 Q3 | 28.28 Million USD | 7.45% |
| 2018 Q2 | 26.32 Million USD | 24.19% |
| 2018 FY | 49.45 Million USD | 106.76% |
| 2017 FY | 23.91 Million USD | -12.22% |
| 2017 Q4 | 23.91 Million USD | -8.75% |
| 2017 Q3 | 26.21 Million USD | -5.02% |
| 2017 Q2 | 27.59 Million USD | 6.63% |
| 2017 Q1 | 25.87 Million USD | -5.02% |
| 2016 Q4 | 27.24 Million USD | 26.63% |
| 2016 FY | 27.24 Million USD | 92.82% |
| 2016 Q2 | 22.04 Million USD | -12.87% |
| 2016 Q3 | 21.51 Million USD | -2.41% |
| 2016 Q1 | 25.3 Million USD | 79.08% |
| 2015 Q3 | 15.02 Million USD | -10.88% |
| 2015 FY | 14.13 Million USD | 37.97% |
| 2015 Q1 | 9.37 Million USD | -8.47% |
| 2015 Q2 | 16.85 Million USD | 79.78% |
| 2015 Q4 | 14.13 Million USD | -5.93% |
| 2014 Q1 | 14.45 Million USD | -8.31% |
| 2014 Q4 | 10.24 Million USD | -17.45% |
| 2014 Q3 | 12.4 Million USD | -10.6% |
| 2014 Q2 | 13.87 Million USD | -3.96% |
| 2014 FY | 10.24 Million USD | -35.02% |
| 2013 Q1 | 19.24 Million USD | 79.77% |
| 2013 FY | 15.76 Million USD | 47.22% |
| 2013 Q4 | 15.76 Million USD | -9.43% |
| 2013 Q3 | 17.4 Million USD | -5.3% |
| 2013 Q2 | 18.37 Million USD | -4.52% |
| 2012 Q2 | 7.89 Million USD | 3413.79% |
| 2012 FY | 10.7 Million USD | 6551.46% |
| 2012 Q4 | 10.7 Million USD | -6.61% |
| 2012 Q1 | 224.68 Thousand USD | 39.59% |
| 2012 Q3 | 11.46 Million USD | 45.2% |
| 2011 Q1 | 133 Thousand USD | -62.25% |
| 2011 FY | 160.95 Thousand USD | -54.31% |
| 2011 Q3 | 76.52 Thousand USD | 0.25% |
| 2011 Q2 | 76.33 Thousand USD | -42.61% |
| 2011 Q4 | 160.95 Thousand USD | 110.34% |
| 2010 FY | 352.29 Thousand USD | -78.93% |
| 2010 Q1 | 1.01 Million USD | -39.11% |
| 2010 Q2 | 1.24 Million USD | 21.99% |
| 2010 Q3 | 579.37 Thousand USD | -53.35% |
| 2010 Q4 | 352.29 Thousand USD | -39.19% |
| 2009 FY | 1.67 Million USD | -68.66% |
| 2009 Q4 | 1.67 Million USD | -21.33% |
| 2009 Q3 | 2.12 Million USD | -28.57% |
| 2009 Q2 | 2.97 Million USD | -31.68% |
| 2009 Q1 | 4.35 Million USD | -18.38% |
| 2008 Q3 | 5.98 Million USD | -16.62% |
| 2008 Q1 | 3.74 Million USD | -11.71% |
| 2008 Q4 | 5.33 Million USD | -10.91% |
| 2008 FY | 5.33 Million USD | 25.82% |
| 2008 Q2 | 7.18 Million USD | 91.83% |
| 2007 FY | 4.24 Million USD | 10516.67% |
| 2007 Q2 | 25.23 Thousand USD | -7.95% |
| 2007 Q4 | 4.24 Million USD | -15.34% |
| 2007 Q1 | 27.41 Thousand USD | -0.08% |
| 2007 Q3 | 5 Million USD | 19752.44% |
| 2006 Q3 | 28.46 Thousand USD | 0.0% |
| 2006 FY | 39.94 Thousand USD | 0.0% |
| 2006 Q4 | 27.43 Thousand USD | -3.61% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.25 Million USD | -5827.492% |
| BIMI International Medical Inc. | 35.71 Million USD | -772.909% |
| China Jo-Jo Drugstores, Inc. | 95.05 Million USD | -227.966% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 312.16 Million USD | 0.131% |
| Leafly Holdings, Inc. | 21.83 Million USD | -1327.777% |
| Leafly Holdings, Inc. | 21.83 Million USD | -1327.777% |
| LifeMD, Inc. | 58.48 Million USD | -433.09% |
| LifeMD, Inc. | 58.48 Million USD | -433.09% |
| TRxADE HEALTH, Inc. | 12.53 Million USD | -2387.49% |
| PetMed Express, Inc. | 175.09 Million USD | -78.051% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | 99.615% |